Argent Trust Company’s Bristol-Myers Squibb BMY Stock Holding History

Argent Trust Company’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	$3.09M	Buy	52,261 +624	+1%	+$39.6K	1.38%	21
2015 Q2	$3.44M	Sell	51,637 -100	-0.2%	-$6.59K	1.37%	19
2015 Q1	$3.34M	Sell	51,737 -15	-0%	-$939	1.36%	20
2014 Q4	$3.06M	Sell	51,752 -2,925	-5%	-$165K	1.24%	22
2014 Q3	$2.8M	Sell	54,677 -4,385	-7%	-$219K	1.09%	25
2014 Q2	$2.87M	Sell	59,062 -2,855	-5%	-$141K	1.01%	28
2014 Q1	$3.22M	Buy	61,917 +150	+0.2%	+$7.98K	1.21%	22
2013 Q4	$3.28M	Buy	61,767 +3,780	+7%	+$193K	1.25%	21
2013 Q3	$2.68M	Buy	57,987 +670	+1%	+$29.4K	1.14%	23
2013 Q2	$2.56M	Buy	+57,317	New	+$2.49M	1.14%	26

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LTI

Laffer Tengler Investments Nashville, Tennessee $782M AUM 33.6% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Argent Trust Company's BMY Position: Q3 2015 in Review

Argent Trust Company increased its Bristol-Myers Squibb (BMY) stake by 1.2% in Q3 2015, buying an estimated $39.6K and bringing the position to 52,261 shares worth $3.09M. The position accounts for 1.38% of the portfolio, ranked #21.

Argent Trust Company first reported a position in BMY in Q2 2013 and has held it in 10 quarters since. The position peaked at $3.44M in Q2 2015. 1,454 funds tracked by Wall St. Rank hold BMY as of Q3 2015.

Argent Trust Company held 52,261 shares of Bristol-Myers Squibb worth $3.09M as of Q3 2015.
Argent Trust Company bought 624 Bristol-Myers Squibb shares in Q3 2015, an estimated $39.6K.
Bristol-Myers Squibb made up 1.38% of Argent Trust Company's portfolio in Q3 2015, its #21 holding.
Argent Trust Company first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 10 quarters since.
Argent Trust Company's Bristol-Myers Squibb position peaked at $3.44M in Q2 2015.
1,454 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2015.

Based on Argent Trust Company's 13F filing for Q3 2015, filed 13 Nov 2015.